Inovalon Results Presentation Deck slide image

Inovalon Results Presentation Deck

Reconciliation Non-GAAP Net Income Inovalon defines Non-GAAP net income as net income or loss calculated in accordance with GAAP, adjusted to exclude tax-affected stock- based compensation expense, acquisition costs, restructuring expense, amortization of acquired intangible assets, tax on equity exercises, and other non-comparable items. The Company defines Non-GAAP diluted net income per share as Non-GAAP net income divided by diluted weighted average shares outstanding. A reconciliation of net income to Non-GAAP net income follows: of Forward-Looking Guidance (In millions, except per share amounts) Reconciliation of Forward-Looking Guidance Net Income to Non-GAAP net income: Net (loss Mincome Stock-based compensation Acquisition costs: Transaction costs Integration costs Contingent consideration accretion Compensatory contingent consideration Amortization of acquired intangible assets Restructuring expense Other non-comparable items (1) Tax impact of add-back items (2) Non-GAAP net income GAAP diluted net (loss)/income per share Non-GAAP diluted net income per share Weighted average shares of common stock outstanding - diluted $ INOV Q2 2018 Earnings Supplement (8.1.18) v1.0.0 $ Guidance Range Twelve Months Ending December 31, 2018 High Low (24) 15 7 7 10 4 45 9 7 (30) 50 (0.16) 0.34 146 $ $ $ (18) 15 780449 10 45 7 (29) (0.12) 0.40 146 Other "non-comparable items include items that are not comparable across reporting periods or items that do not otherwise relate to the Company's ongoing financial results, such as certain employee related expenses attributable to advancements in automation and operational efficiencies, and legal expenses beyond those in the normal course of business. Non-comparable items are excluded from Adjusted EBITDA in order to more effectively assess the Company's period over period and ongoing operating performance A 30% tax rate is assumed in order to approximate the Company's effective corporate tax rate. 28
View entire presentation